Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Brainstorm Cell Therapeutics Inc. - Common Stock
(NQ:
BCLI
)
1.170
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Jul 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Brainstorm Cell Therapeutics Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
Next >
12 Health Care Stocks Moving In Thursday's After-Market Session
↗
September 28, 2023
Via
Benzinga
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Brainstorm Cell Therapeutics Inc. Investors to Inquire About Securities Class Action Investigation – BCLI
September 28, 2023
From
The Rosen Law Firm, P.A.
Via
Business Wire
Nasdaq Rises Over 100 Points; Accenture Shares Fall After Q4 Results
↗
September 28, 2023
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining over 100 points on Thursday. The Dow traded up 0.40% to 33,683.43 while the NASDAQ rose 0.95% to 13,217.46. The S&P 500...
Via
Benzinga
Topics
Stocks
10 Health Care Stocks With Whale Alerts In Today's Session
↗
September 28, 2023
Via
Benzinga
Brainstorm Cell's Earnings: A Preview
↗
August 11, 2023
Via
Benzinga
Brainstorm Cell's Earnings Outlook
↗
May 12, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
↗
September 28, 2023
Via
Benzinga
Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
September 28, 2023
Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant...
Via
Benzinga
Crude Oil Moves Lower; CarMax Posts Downbeat Earnings
↗
September 28, 2023
U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining 1% on Thursday. The Dow traded up 0.58% to 33,745.23 while the NASDAQ rose 1% to 13,223.61. The S&P 500 also rose,...
Via
Benzinga
Topics
Stocks
Benzinga's Top Ratings Upgrades, Downgrades For September 28, 2023
↗
September 28, 2023
Via
Benzinga
Dow Rises 80 Points; US Jobless Claims Edge Higher
↗
September 28, 2023
U.S. stocks traded higher this morning, with the Dow Jones gaining around 80 points on Thursday. Following the market opening Thursday, the Dow traded up 0.24% to 33,630.52 while the NASDAQ rose 0.12%...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Thursday's Pre-Market Session
↗
September 28, 2023
Via
Benzinga
FDA Advisory Panels Gives Thumbs Down To BrainStorm's Lead Therapy
↗
September 28, 2023
The FDA's Cellular, Tissue and Gene Therapies Advisory Committee meeting reviewing BrainStorm Cell Therapeutics Inc's (NASDAQ: BCLI) NurOwn application voted that NurOwn did not demonstrate substantial...
Via
Benzinga
Why Galecto Shares Are Trading Higher By Around 30%; Here Are 20 Stocks Moving Premarket
↗
September 27, 2023
Gainers
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
↗
September 26, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
September 25, 2023
Via
Benzinga
Gold Moves Lower; TransCode Therapeutics Shares Surge
↗
September 25, 2023
U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite trading higher by around 30 points on Monday. The Dow traded down 0.07% to 33,939.93 while the NASDAQ rose 0.24% to...
Via
Benzinga
Topics
Stocks
12 Health Care Stocks Moving In Monday's Intraday Session
↗
September 25, 2023
Via
Benzinga
Why Brainstorm Cell Therapeutics Shares Are Trading Lower By 33%? Here Are Other Stocks Moving In Monday's Mid-Day Session
↗
September 25, 2023
Gainers TransCode Therapeutics, Inc. (NASDAQ: RNAZ) shares jumped 308% to $2.71 after the company announced pre-clinical gliblastoma results with its lead candidate, TTX-MC138.
Via
Benzinga
Nasdaq Turns Higher; SCYNEXIS Shares Plunge
↗
September 25, 2023
U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite trading higher on Monday. The Dow traded down 0.01% to 33,962.53 while the NASDAQ rose 0.26% to 13,246.15. The S&P 500...
Via
Benzinga
Topics
Stocks
Why Is Neurodegenerative Disease-Focused Brainstorm Cell Therapeutics Stock Plunging Today?
↗
September 25, 2023
Brainstorm Cell Therapeutics Inc (NASDAQ: BCLI) shares are sinking after the FDA released briefing documents ahead of the adcomm meeting scheduled on
Via
Benzinga
U.S. Stocks Open Lower; Chicago Fed Index Falls In August
↗
September 25, 2023
U.S. stocks traded mostly lower this morning, with the Dow Jones trading falling around 80 points on Monday. Following the market opening Monday, the Dow traded down 0.26% to 33,875.83 while the NASDAQ...
Via
Benzinga
Topics
Economy
Stocks
12 Health Care Stocks Moving In Monday's Pre-Market Session
↗
September 25, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
↗
September 25, 2023
It's time for another dive into the biggest pre-market stock movers as we check out all of the latest news on Monday morning!
Via
InvestorPlace
Roth MKM Analyst Projects An Impressive Price Target Of $15 Over The Next 12 Months For BioRestorative Therapies (NASDAQ: BRTX), Says "Low Valuation Undeserved"
↗
September 14, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) (“BioRestorative”) is a clinical-stage biotech company that is developing cell-based therapies to treat chronic lumbar disc disease and metabolic conditions...
Via
Benzinga
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Quarter
↗
July 27, 2023
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
Via
Benzinga
BrainStorm Cell Therapeutics Shares Fall After Updated Biomarker Data From Lead Cell Therapy Candidate
↗
July 07, 2023
BrainStorm Cell Therapeutics Inc (NASDAQ: BCLI) presented new biomarker data from the Phase 3 trial of its late-stage investigational amyotrophic lateral sclerosis (ALS) treatment, NurOwn, at the 2023...
Via
Benzinga
BioRestorative Therapies' Drug Candidate BRTX-100 Passes Safety Test With Flying Colors, Moves Ahead With Phase 2 And Looks To Expand Pipeline Opportunities
↗
July 06, 2023
BioRestorative Therapies Inc. (NASDAQ: BRTX) has received a unanimous recommendation to proceed in its Phase 2 clinical trial for chronic lumb
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
↗
June 20, 2023
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
↗
March 31, 2023
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
